UPDATE: Intercept Pharma (ICPT) Changes Main Goal in Phase Three Nash Study with OCA - Bloomberg
Tweet Send to a Friend
(Updated - February 10, 2017 8:41 AM EST)
Intercept Pharma (NASDAQ: ICPT) said ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Intercept Pharma (NASDAQ: ICPT) said ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
